Dabur India Seeks Shareholder Vote for Sesa Care Merger

Dabur India is moving forward with its plan to merge with Sesa Care Private Limited, a significant step in expanding its footprint in the Ayurvedic hair care sector. The company is now seeking the final approval from its shareholders.

Shareholder Meeting Set for May 2, 2026

A pivotal meeting for Dabur India's shareholders is scheduled for May 2, 2026. During this session, they will vote on the proposed merger plan between Dabur India and Sesa Care. This shareholder meeting is a requirement set by the National Company Law Tribunal (NCLT) following its order on March 12, 2026. Shareholders will be able to participate and cast their votes remotely via video conferencing or audio-visual means, ensuring broad accessibility.

Strategic Push into Ayurvedic Hair Care

The planned merger with Sesa Care is a strategic initiative designed to strengthen Dabur's position in the competitive Ayurvedic hair oil market. Sesa Care brings a portfolio of premium Ayurvedic hair care products. Dabur intends to leverage its extensive distribution network and market expertise to drive growth for these brands. This integration is expected to create significant operational efficiencies and optimize the combined entity's resources.

Acquisition of Sesa Care: The Background

Dabur India first agreed to merge with Sesa Care in October 2024. At that time, Dabur acquired a 51% stake in Sesa Care, valuing the company at an enterprise value estimated between ₹315 crore and ₹325 crore. Sesa Care is recognized as a leader in the Ayurvedic hair care market. This move aligns with Dabur's ongoing strategy of expanding through acquisitions, similar to its previous integrations of businesses like the Balsara group companies and Fem Care Pharma. The process has involved obtaining earlier approvals from Sesa Care's creditors and shareholders, paving the way for the current NCLT directive and the upcoming shareholder vote.

Path Forward Post-Approval

If shareholders give their approval, it will clear the path for the next stages of regulatory clearance. Following official approval, Dabur India will begin integrating Sesa Care's operations and brands into its broader business structure.

Potential Risks and Challenges

The merger process faces several potential risks. Shareholder dissent or failure to secure the required majority vote could halt the deal. There's also the possibility of delays in obtaining final approval from the NCLT or other necessary statutory clearances. Furthermore, challenges may arise in achieving the projected cost savings and revenue growth targets after the integration is complete. It's worth noting that Dabur and its subsidiaries have faced past lawsuits in the U.S. and Canada concerning hair products, though these are in early litigation stages and some subsidiaries were dismissed from one case.

Competitive Landscape

Dabur operates within the fast-moving consumer goods (FMCG) sector, facing strong competition from major players like Hindustan Unilever (HUL), ITC, Marico, and Emami. Competitors such as HUL and Marico also possess substantial portfolios in personal and hair care products, underscoring the importance of strategic consolidation for Dabur to maintain and grow its market share. Patanjali Ayurved remains a key rival, particularly in the Ayurvedic and natural products segment where Dabur has a long-standing presence.

Key Dates to Monitor

Investors and stakeholders will be closely watching the outcome of the shareholder meeting on May 2, 2026. Subsequent NCLT orders and final approvals will be crucial. The company targets April 1, 2026, as the appointed date for the scheme's effectiveness, along with details on the share swap ratio and any remaining consideration for Sesa Care's shares.